674 results on '"Paganelli, G"'
Search Results
2. Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials
3. Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review
4. Clinical value of negative 68Ga-PSMA PET/CT in the management of biochemical recurrent prostate cancer patients
5. CO-14.1 - NUCLEAR MEDICINE THERAPY WITH 177LU-PSMA-617 AND 177LU-DOTATATE: DOSE RATE PREDICTION AT LATE TIME FROM A SINGLE MEASUREMENT AT EARLY RELEASE TIME: A MULTICENTRIC ITALIAN STUDY
6. Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors
7. Gene transcript analysis blood values correlate with 68Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status
8. B7 - Radium-223 with concomitant bone-targeting agents in metastatic castration-resistant prostate cancer (CRPC) patients treated in an international early access program (EAP)
9. B19 - Patient (pt) characteristics and treatment patterns in the radium (Ra)-223 REASSURE observational study
10. B8 - Changes in alkaline phosphatase (ALP) dynamics and overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 in an international early access program (EAP)
11. Pattern of epithelial cell proliferation in colorectal mucosa of patients with large bowel adenoma or cancer: an ECP case-control study
12. Egg-Related Salmonella enteritidis, Italy, 1991
13. The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series
14. Usefulness of[111In-DTPA0] octreotide scintigraphy in a family with von Hippel-Lindau disease
15. Role of multidetector CT and FDG-PET/CT in the diagnosis of local and distant recurrence of resected rectal cancer
16. UP43 - Therapy with 177Lu-PSMA-617 in advanced mCRPC patients: Results of the phase 2 prospective trial IRST-185.03 (EUDRACT: 2016-002732-32)
17. 1826P Lutetium-177-PSMA in pre- and post-taxane mCRPC setting: Results from a phase II clinical trial
18. Lymphatic mapping to tailor selective lymphadenectomy in cN0 tongue carcinoma: beyond the sentinel node concept
19. Carcinoid crisis induced by receptor radionuclide therapy with 90Y-DOTATOC in a case of liver metastases from bronchial neuroendocrine tumor (atypical carcinoid)
20. A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases
21. Optimised nuclear medicine method for tumour marking and sentinel node detection in occult primary breast lesions
22. Preoperative PET/CT in early-stage breast cancer: is the TNM classification enough?
23. Integrating targeted treatments with tumor biology and molecular imaging in the current and future management of neuroendocrine gastrointestinal tumors
24. Effect of complex polyphenols and tannins from red wine (WCPT) on chemically induced oxidative DNA damage in the rat
25. Right pelvic mass in a patient with a radically resected carcinoid of the appendix
26. Development of axillary surgery in breast cancer
27. Optimal power management of an experimental fuel cell/supercapacitor-powered hybrid vehicle
28. Sentinel lymph node biopsy for localised ductal carcinoma in situ?
29. Combination of monoclonal antibodies for radioimmunoguided surgery
30. Role of fluorodeoxyglucose positron emission tomography in the staging of patients with breast cancer candidated to surgery
31. Colite ulcéreuse chronique et cancer colorectal
32. Combined use of111In-labeled pentetreotide and three-step immunoscintigraphy with antichromogranin a monoclonal antibody in the diagnosis of pituitary adenomas
33. Thyroid disease in northern Italian children born around the time of the Chernobyl nuclear accident
34. Cerebrospinal fluid diffusion of Zevalin® after high-activity treatment and stem cell support in a patient affected by diffuse large B-cell non-Hodgkinʼs lymphoma with central nervous system involvement
35. Safety of sentinel node biopsy in pregnant patients with breast cancer
36. 15. Clinical Results in Lymphoma II: 065 YTTRIUM-90 IBRITUMOMAB TIUXETAN (ZEVALIN) INDUCES HIGH RESPONSE RATES IN PREVIOUSLY TREATED PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA (DLBCL)
37. Safety of sentinel node biopsy in pregnant patients
38. Is CD20 the only target available for radionuclide therapy in lymphoproliferative disorders?
39. Optimised lymphoscintigraphy in pregnant patients with breast cancer is safe
40. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-d-glucose positron emission tomography in patients with coronary artery disease
41. The use of standardized uptake values for assessing FDG uptake with PET in oncology: a clinical perspective
42. EDITORIAL
43. Radioguided occult lesion localization (ROLL) in breast cancer: maximizing efficacy, minimizing mutilation
44. Innovation in early breast cancer surgery: radio-guided occult lesion localization and sentinel node biopsy
45. Bone scan had no role in the staging of 765 consecutive operable T1-2N0-1 breast cancer patients without skeletal symptoms
46. Radiation protection in radioguided surgery of breast cancer
47. Comparison of radioguided excision with wire localization of occult breast lesions
48. OPTIMAL CONTROL THEORY APPLIED TO HYBRID FUEL CELL POWERED VEHICLE
49. Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia
50. Biodistribution in tumour-bearing mice of two 90Y-labelled biotins using three-step tumour targeting
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.